FDA-cleared and IVDD for the quantitative determination of calprotectin in human stool, in vitro diagnostic use as an aid in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC), and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other clinical and laboratory findings.
ALPCO’s Calprotectin IT Assay combines the clinical sensitivity and specificity clinicians expect with the efficiency and repeatability today’s laboratories require.
Take Control of Your Calprotectin Testing
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay
One free kit per laboratory. Void where prohibited.
Clinically Accurate
Clinical sensitivity of 90.5% - few false negatives
Clinical specificity of 93.4% - few false positives
Reliable
AMR of 11 -10,000 µg/g* - broad range of reportable quantitative results
Inter-lot CV of only 4.1% - repeatable performance
Fast
Testing of >400 samples / hour** - high throughput
STAT results in 10 minutes** - fast turn-around
User Friendly
Compatible with standard clinical chemistry analyzers - minimal training and hands-on time
Universal stool extraction device - single preparation with no manual weighing
Cost Effective
Only 2 non-reportables per day - minimal cost for low and high volume testing
Cost savings vs. send-out with revenue potential and CAGR of 6%
*With automatic 1:10 dilution **Based on the Beckman AU680 analyzer
Your Fecal Calprotectin Testing,
Elevated.
No matter how you are currently running your fecal calprotectin testing, ALPCO's new Calprotectin Immunoturbidimetric Assay will take your testing to the next level.